New antibody-drug compound halts growth of metastatic breast tumors

[News]

A new antibody-drug compound shrank or halted the growth of metastatic breast tumors in almost half of a group of patients whose HER2-positive cancer had become resistant to standard therapies, according to early data from a multicenter Phase 2 clinical trial led by a Dana-Farber Cancer Institute researcher.

More... (http://www.news-medical.net/news/20091214/New-antibody-drug-compound-halts-growth-of-metastatic-breast-tumors.aspx)